GHRS — GH Research Income Statement
0.000.00%
- $606.65m
- $446.06m
- 35
- 33
- 77
- 46
Annual income statement for GH Research, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 20-F | 20-F | 20-F |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 0.31 | 0.446 | 15.1 | 30.6 | 41.2 |
Operating Profit | -0.31 | -0.446 | -15.1 | -30.6 | -41.2 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.31 | -0.446 | -9.2 | -22.5 | -35.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.31 | -0.446 | -9.2 | -22.5 | -35.6 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.31 | -0.446 | -9.2 | -22.5 | -35.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.31 | -0.446 | -9.2 | -22.5 | -35.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.006 | -0.009 | -0.211 | -0.432 | -0.684 |
Dividends per Share |